Tilray Brands to expand into the US marijuana market? Why you shouldn’t count on that anytime soon
Marijuana rescheduling may have taken place in the U.S., but that doesn’t mean legalization will happen anytime soon.
Marijuana Companies Eye Investment Boom After Trump Admin Reschedules Drug
Following the recent drug rescheduling from the Trump Administration, medicinal marijuana companies are preparing to raise nearly $20 million in private funding.
3 Cannabis Stocks That Could Soar After Marijuana Rescheduling
These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.
This Trump Policy Shift Could Be a Game Changer for Cannabis Stocks: 2 Stocks to Watch Now
The cannabis industry has spent years navigating regulatory uncertainty, limiting the growth and profitability of marijuana companies despite strong demand. However, a fresh policy push from President …
Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce?
Canopy Growth (NASDAQ: CGC) is a Canadian marijuana company. When it first came public marijuana was a hot sector, but investor enthusiasm has waned. The stock has since declined to the point where it …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
3 Cannabis Stocks That Could Soar After Marijuana Rescheduling
These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.
This Trump Policy Shift Could Be a Game Changer for Cannabis Stocks: 2 Stocks to Watch Now
The cannabis industry has spent years navigating regulatory uncertainty, limiting the growth and profitability of marijuana companies despite strong demand. However, a fresh policy push from President …
Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce?
Canopy Growth (NASDAQ: CGC) is a Canadian marijuana company. When it first came public marijuana was a hot sector, but investor enthusiasm has waned. The stock has since declined to the point where it …
Trump just eased federal marijuana laws. Is there an investment case for cannabis ETFs right now?
Gradual easing of restrictions on marijuana continues.
Cannabis stocks lose buzz despite this landmark decision
Cannabis stocks rose Thursday after the Trump administration, in a landmark decision, reclassified marijuana as a less-dangerous drug. But early stock gains faded. Marijuana now goes from being …
Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to …
How does marijuana rescheduling affect cannabis companies now?
Some operators are seeking partnerships for clinical studies, while others are developing strategies to scale their operations.
Cannabis MSOs to see increased investment, lower taxes from reclassification
Marijuana’s Schedule III shift could boost cannabis MSOs via new capital access and Section 280E tax relief. Read more here.
Pot stocks rise as Trump reschedules marijuana as a less-dangerous drug: AP
Shares of cannabis companies rose in the premarket on Thursday after the Associated Press reported President Donald Trump’s acting attorney general signed an order rescheduling state-licensed medical …
Recent Comments